Tumour necrosis factor α blockade and the risk of vasculitis [5]

Annals of the Rheumatic Diseases

Volumn 65, Issue 11, 2006, Pages 1534-1535

  De Bandt, M ^a   Saint Marcoux, B ^a  

^a Centre Hospitalier Robert Ballanger CHRB   (France)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA INHIBITOR;

ARTHRITIS; CLINICAL FEATURE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LETTER; PRIORITY JOURNAL; REMISSION; RISK FACTOR; SPONDYLITIS; VASCULITIS;

ADULT; ANTIRHEUMATIC AGENTS; BIOLOGICAL RESPONSE MODIFIERS; DRUG ERUPTIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; VASCULITIS;

EID: 33750311701     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.051888     Document Type: Letter

References (9)

1. McIlwain L, Carter JD, Bin-Sagheer S, Vasey FB, Nord J. Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab. J Clin Gastroenterol 2003;36:411-13.
2. McCain ME, Quinet RJ, Davis WE. Etanercept and infliximab associated with cutaneous vasculitis. Rheumatology (Oxford) 2002;41:1450-2.
3. Richette P, Dieudé P, Damiano J, et al. Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for RA. J Rheumatol 2004;31:2079-81.
4. Berthelot JM, Glemarec J, Maugars Y, Prost A. Lethal medium-vessel panarteritis mimicking deep sepsis following etanercept and minocycline therapy in a patient with severe rheumatoid arthritis. Rheumatology (Oxford) 2002;41:703-5.
5. Roux CH, Brocq O, Albert C Breuil V, Euller-Ziegler L. Cutaneous vasculitis and glomerulonephritis in a patient taking the anti-TNF alpha agent etanercept for rheumatoid arthritis. Jt Bone Spine 2004;71:444-5.
6. Mohan N, Edwards ET, Cupps TR, et al. Leukocytoclastic vasculitis associated with TNF-a blocking agents. J Rheumatol 2004;31:1955-9.
7. Mor A, Bingham C III, Barisoni L, Lydon E, Belmont HM. Proliferative lupus nephritis and leukocytoclastic vasculitis during treatment with etanercept. J Rheumatol 2005;32:740-3.
8. Uvermore PA, Murray KJ. Anti-tumour necrosis factor therapy associated with cutaneous vasculitis. Rheumatology (Oxford) 2002;41:1450-2.
9. Jarrett SJ, Cunnane G, Conaghan PG, Bingham SJ, Buch MH, Quinn MA et al. Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol 2003;30:2287-91.